Fund launch · 2026-11-04 · Healthcare
Yosemite launches $350.0M fund
60
AI Score
Fund size
$350.0M
Type
Fund launch
GP
Not disclosed
HQ
—
Why it matters: Yosemite's second fund doubling to $350M shows how a philanthropy-plus-venture model is being used to back cancer research, with Amgen, AbbVie and MIT among its LPs.
Reed Jobs's cancer-focused venture firm Yosemite closed its second fund at $350 million.
- Participants:
- Amgen, AbbVie, MIT, Memorial Sloan Kettering, John Doerr
- Source:
- Fortune Term Sheet ↗ · Midu summary
Deal Dossier PRO
Pro feature
Deal Dossier for Yosemite
Company, lead and participating investors, founders, and verified public contact channels — sourced, generated on demand.
Generate dossier — ProFigures marked company-reported are unaudited. Not investment advice. Request a correction or removal (team@midu.si).
Recent Healthcare rounds
Subscribe to the newsletters
Free, by email. No account needed. Pick one or both.
No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.
Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing